Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas

Journal of Clinical Investigation

Volumn 101, Issue 5, 1998, Pages 1102-1110

  Nambu, Yoshihiro ^a,b   Hughes, Steven J ^b   Rehemtulla, Alnawaz ^b   Hamstra, Daniel ^b   Orringer, Mark B ^b   Beer, David G ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

A549; Fas FLAG; Fas APO 1; Posttranslational modification; Pulmonary adenocarcinoma

Indexed keywords

COMPLEMENTARY DNA; FAS ANTIGEN; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032032577     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1692     Document Type: Article

References (31)

1. Garfinkel, L. 1991. Cancer statistics and trends. In American Cancer Society Textbook of Clinical Oncology. A.I. Holleb, D.J. Fink, and G.P. Murphy, editors. American Cancer Society. Atlanta, GA. 1-6.
2. Wyliie, A.H., J.F.R. Kerr, and A.R. Currie. 1980. Cell death: significance of apoptosis. Int. Rev. Cytol. 68:251-306.
3. Thompson, C.B. 1995. Apoptosis in pathogenesis and genes and treatment of disease. Science. 267:1456-1461.
4. Nagata. S., and P. Goldstein. 1995. The Fas death factor. Science. 267: 1449-1456.
5. Owen-Schaub, L.B., R. Radinsky, E. Krunzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580-1586.
6. Cheng, J., T. Zhou, C. Liu, J.P. Shapiro, M.J. Brauer, M.C. Keifer, P.J. Barr, and J.D. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1759-1762.
7. Owen-Schaub, L.B., L.S. Angelo, R. Radinsky, C.F. Ware, T.G. Genser, and D.P. Bartos. 1995. Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis? Cancer Lett. 94:1-8.
8. Cascino, I., G. Fiucci, G. Papoff, and G. Ruberti. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:1157-1164.
9. Midis, G.P., Y. Shen, and L.B. Owen-Schaub. 1996. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res. 56:3870-3874.
10. World Health Organization. 1988. The World Health Organization histological typing of lung tumors (second edition). Am. J. Clin. Pathol. 77:123-136.
11. American Joint Committee of Cancer. 1992. Manual for Staging of Lung Cancer. O.H. Beahrs, D.E. Henson, R.V.P. Hutter, and B.J. Kennedy, editors. Lippincott, Philadelphia. PA. 115-119.
12. Nicoletti, I., G. Mgliorati, M.C. Pagliacci, F. Grignani, and C. Riccadi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:271-279.
13. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M.A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry. 13:795-808.
14. Buffone, G.J., and G.J. Darlington. 1985. Isolation of DNA from biological specimens without extraction with phenol. Clin. Chem. 31:164-165.
15. Hanson, L.A., E.O. Nuzum, B.C. Jones, A.M. Malikinson, and D.G. Beer. 1993. Expression of the glucocorticoid receptor and Ki-ras genes in urethan-induced mouse lung tumors and transformed cell lines. Exp. Lung Res. 17: 371-387.
16. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66: 233-243.
17. Davies, M.V., and R.J. Kaufman. 1992. Internal translation initiation in the design of improved expression vectors. Curr. Opin. Biotechnol. 3:512-517.
18. Wada, N., M. Matsumura, Y. Ohba, N. Kobayashi, T. Takizawa, and Y. Nakanishi. 1995. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270:18007-18012.
19. Jaattella, M., M. Benedict, M. Tewari, J.A. Shayman, and V.M. Dixit. 1995. Bcl-X and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene. 10:2297-2305.
20. Weller, M., K. Frei, P. Groscurth, P.H. Krammer, Y. Yonekawa, and A. Fontana. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94:954-964.
21. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:505-512.
22. Kaufman, R.J. 1990. Vectors used for expression in mammalian cells. Methods Enzymol. 185:487-511.
23. Rehemtulla, A., and R.J. Kaufman. 1992. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood. 79:2349-2355.
24. Weller, M., U. Malipiero, A. Rensing-Ehl, P.J. Barr, and A. Fontana. 1995. Fas/APO-1 gene transfer for human malignant glioma. Cancer Res. 55: 2936-2944.
25. Keane, M.M., S.A. Ettenberg, G.A. Lowrey, E.K. Russell, and S. Lipkowitz. 1996. Fas expression and function in normal and malignant breast cell lines. Cancer Res. 56:4791-4798.
26. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K-M. Debatin, P.H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415-429.
27. Hockenberry, D., G. Nuñez, C. Milliman, R.D. Screiber, and S.J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed death. Nature. 348:334-336.
28. Xerri, L., C. Nadine, P. Park, and F. Birg. 1995. Search for rearrangements and/or allelic loss of the fas/APO-1 gene in 101 human lymphomas. Am. J. Clin. Pathol. 104:424-430.
29. Cai, Z., R. Stancou, M. Korner, and S. Chouab. 1996. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF-7 tumor cells. Int. J. Cancer. 68:535-546.
30. Niehans, G.A., T. Brunner, S.P. Frizelle. J.C. Liston, C.T. Salerno, D.J. Knapp, D.R. Green, and R.A. Kratzke. 1997. Human lung carcinomas express Fas ligand. Cancer Res. 57:1007-1012.
31. Hughes, S.J., Y. Nambu, O.S. Soldes, D. Hamstra, A. Rehemtulla, M.D. Iannettoni, M.B. Orringer, and D.G. Beer. 1997. Fas/APO-1 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma. Cancer Res. 57:5571-5578.